CRYOLIFE

Vasamed (OTCMKTS:VSMD) and CryoLife (NYSE:CRY) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, analyst recommendations, institutional ownership and earnings. Analyst Ratings This is a summary of recent recommendations and price targets for Vasamed and CryoLife, as provided []

New York State Teachers Retirement System lowered its stake in shares of CryoLife, Inc. (NYSE:CRY) by 0.8% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 88,257 shares of the medical equipment providers stock after selling 700 shares during the quarter. New York State Teachers Retirement Systems holdings in CryoLife were worth $1,967,000 as []

CryoLife, Inc. (NYSE:CRY) CAO Amy Horton sold 2,500 shares of CryoLife stock in a transaction dated Wednesday, December 8th. The shares were sold at an average price of $18.57, for a total value of $46,425.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. []

DUBLIN--(BUSINESS WIRE)--The "Medical Adhesives and Sealants - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com''s offering. Amid the COVID-19 crisis, the global market for Medical Adhesives and Sealants estimated at US$10.3 Billion in the year 2020, is projected to reach a revised size of US$15.2 Billion by 2027, growing at a CAGR of 5.6% over the analysis period 2020-2027. Acrylic, one of the segments analyzed in the report, is projected to record a 4.7

State of Alaska Department of Revenue lifted its holdings in CryoLife, Inc. (NYSE:CRY) by 6.0% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 28,672 shares of the medical equipment providers stock after acquiring an additional 1,615 shares during the period. State of Alaska Department of Revenues []

DUBLIN--(BUSINESS WIRE)--The "Global Soft Tissue Repair Market 2021-2028" report has been added to ResearchAndMarkets.com''s offering. The global soft tissue repair market is expected to rise with a CAGR of 6.16% in the estimated period 2021-2028. Companies Mentioned Allergan Athersys Inc Bard Peripheral Vascular Inc Baxter International Inc Becton Dickinson and Company (Bd) Boston Scientific Corporation Cryolife Inc Johnson & Johnson Integra Lifesciences Corporation Medtronic plc Organogene

CryoLife (NYSE:CRY) and PAVmed (NASDAQ:PAVM) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, analyst recommendations, risk, institutional ownership, profitability and earnings. Analyst Recommendations This is a breakdown of recent ratings for CryoLife and PAVmed, as provided by MarketBeat.com. []

The global Bone Glue market was valued at $1,981.77 Mn in 2020 and is expected to reach $3,081.65 Mn by 2028 growing at a CAGR of 5.7% over the forecast period. The concept of a “bone glue” to repair

CryoLife (NYSE:CRY) is scheduled to issue its quarterly earnings data after the market closes on Thursday, November 4th. Analysts expect the company to announce earnings of $0.04 per share for the quarter. Parties interested in participating in the companys conference call can do so using this link. CryoLife (NYSE:CRY) last posted its quarterly earnings results []

Hemostats Market Size | 2021 Covid-19 Impact On Healthcare Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional Forecast To 2028 is latest study published by Fortune Business Insights. The Global Hemostats

Dublin, Sept. 03, 2021 (GLOBE NEWSWIRE) -- The "Transcatheter Heart Valve Replacement Devices - Market Insights, Competitive Landscape and Market Forecast - 2026" drug pipelines has been added to ResearchAndMarkets.com''s offering. The Transcatheter Heart Valve Replacement Devices (THVR) market report provides an overview of THVR, applications of THVR as well as its PEST Analysis. Additionally, the report provides insight on the THVR market share of the individual THVR, current and forecasted THVR market size from 2018 to 2026, segmented by seven major markets. The report also covers the market drivers, market barriers and unmet needs to curate the best of opportunities and assesses underlying potential of the market. Transcatheter Heart Valve Replacement Devices (THVR) - Competitive Analysis This segment of the report provides a brief competitive analysis of THVR, to help understand the competition in the market. It gives a comparative understanding of the products based on types. List of Companies: Edwards Lifesciences, Medtronic, Livanova plc, Abbott, Boston Scientific Corporation, CryoLife Inc among others.

Global Tissue and Organ Transplantation Market to Surpass US$ 25.6 Billion at CAGR of +9% by 2028. A transplant is an organ, tissue or a group of cells removed from one person (the donor) and surgically transplanted into another person (the

The Endovascular Aneurysm Repair Devices Market is expected to grow at a CAGR of 6.1 % and is poised to reach $XX Billion by 2027 as compared to $XX Billion in 2020 Recent research from Decisive Markets Insights looks at the

Dublin, Aug. 18, 2021 (GLOBE NEWSWIRE) -- The "Global Regenerative Medicine Market Outlook 2029" report has been added to ResearchAndMarkets.com''s offering.

Corneal transplant surgery is a medical operation that replaces a portion of a patient''s cornea with corneal tissue from a donor. In reality, the cornea is the clear, dome-shaped surface of the eye. It is a huge region of the